Serum periostin is not a good biomarker to identify Th2-driven inflammation in COPD

O. Carpaij (Groningen, Netherlands), F. Muntinghe (Groningen, Netherlands), M. Wagenaar (Groningen, Netherlands), J. Habing (Groningen, Netherlands), W. Timens (Groningen, Netherlands), H. Kerstjens (Groningen, Netherlands), M. Nawijn (Groningen, Netherlands), L. Kunz (Leiden, Netherlands), P. Hiemstra (Leiden, Netherlands), C. Holweg (South San Francisco, California, United States of America), W. Tew (South San Francisco, California, United States of America), M. Van Den Berge (Groningen, Netherlands)

Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Session: Studying novel biomarkers in asthma and COPD
Session type: Thematic Poster
Number: 962
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Carpaij (Groningen, Netherlands), F. Muntinghe (Groningen, Netherlands), M. Wagenaar (Groningen, Netherlands), J. Habing (Groningen, Netherlands), W. Timens (Groningen, Netherlands), H. Kerstjens (Groningen, Netherlands), M. Nawijn (Groningen, Netherlands), L. Kunz (Leiden, Netherlands), P. Hiemstra (Leiden, Netherlands), C. Holweg (South San Francisco, California, United States of America), W. Tew (South San Francisco, California, United States of America), M. Van Den Berge (Groningen, Netherlands). Serum periostin is not a good biomarker to identify Th2-driven inflammation in COPD. 962

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: